Switzerland-headquartered Roche, the world’s largest biotech company and the global leader in in-vitro diagnostics, is acquiring Nasdaq-listed 89bio, a clinical-stage biopharmaceutical company pioneering the development of innovative therapies for the…
Subscription required
This content is for Subscribers only. To access 4,800+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more